Management Board meeting: 3 October 2024

The Management Board is an integral governance body of the Agency. It has a supervisory role with general responsibility for budgetary and planning matters, the appointment of the Executive Director and the monitoring of the Agency's performance.

• Date:
  Ceturtdiena, 3 Oktobris 2024, Visu dienu
• Vieta:
  European Medicines Agency, Amsterdam, the Netherlands

Documents

Minutes of the 125th meeting of the EMA Management Board: 3 October 2024

Adopted Reference Number: EMA/MB/449773/2024

Agenda for the 125th meeting of the EMA Management Board: 3 October 2024

Adopted Reference Number: EMA/MB/377084/2024

Outcome of written procedures finalised during the period from 04 June 2024 to 25 September 2024

Adopted Reference Number: EMA/MB/292679/2024

Mandate of joint HMA-EMA Network Data Steering Group

Reference Number: EMA/419729/2024

Seizing opportunities in a changing medicines landscape: The European medicines agencies network strategy 2028 (draft)

Draft: consultation closed Consultation dates: 09/10/2024 to 30/11/2024 Reference Number: EMA/376542/2024 Summary:

The European Medicines Agencies Network Strategy to 2028 will guide the network as it seizes opportunities and meets the challenges of the near future. This includes preparing for and responding to public health emergencies and threats such as antimicrobial resistance.

Comments should be provided using the EU survey form below:

Public consultation on European Medicines Agencies Network Strategy to 2028

Towards the European medicines agencies network strategy 2028: Reflection paper

Reference Number: EMA/297150/2024

EMA policy on handling of competing interests of scientific committee members and experts: Draft for public consultation

Draft: consultation closed Consultation dates: 10/10/2024 to 10/11/2024 Reference Number: EMA/54457/2024

European Medicines Agency mid-year report 2024 (January-June 2024)

Reference Number: EMA/298094/2024